- Home
- IVA vs AIO Comparison
IVA vs AIO Comparison
Compare IVA & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- AIO
- Stock Information
- Founded
- IVA 2011
- AIO 2019
- Country
- IVA France
- AIO United States
- Employees
- IVA N/A
- AIO N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- AIO Finance/Investors Services
- Sector
- IVA Health Care
- AIO Finance
- Exchange
- IVA Nasdaq
- AIO Nasdaq
- Market Cap
- IVA 769.0M
- AIO 808.3M
- IPO Year
- IVA 2020
- AIO N/A
- Fundamental
- Price
- IVA $5.61
- AIO $24.36
- Analyst Decision
- IVA Strong Buy
- AIO
- Analyst Count
- IVA 6
- AIO 0
- Target Price
- IVA $15.33
- AIO N/A
- AVG Volume (30 Days)
- IVA 74.4K
- AIO 141.5K
- Earning Date
- IVA 09-26-2025
- AIO 01-01-0001
- Dividend Yield
- IVA N/A
- AIO 9.05%
- EPS Growth
- IVA N/A
- AIO N/A
- EPS
- IVA N/A
- AIO N/A
- Revenue
- IVA $14,591,573.00
- AIO N/A
- Revenue This Year
- IVA $80.35
- AIO N/A
- Revenue Next Year
- IVA N/A
- AIO N/A
- P/E Ratio
- IVA N/A
- AIO N/A
- Revenue Growth
- IVA N/A
- AIO N/A
- 52 Week Low
- IVA $1.53
- AIO $15.09
- 52 Week High
- IVA $6.50
- AIO $20.25
- Technical
- Relative Strength Index (RSI)
- IVA 60.84
- AIO 50.53
- Support Level
- IVA $5.21
- AIO $23.80
- Resistance Level
- IVA $5.78
- AIO $24.85
- Average True Range (ATR)
- IVA 0.38
- AIO 0.36
- MACD
- IVA -0.02
- AIO 0.04
- Stochastic Oscillator
- IVA 54.82
- AIO 53.33
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest
Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.